A pilot study to characterise gaze patterns during driving among people who use methamphetamine versus people who have not used methamphetamine

Swinburne University of Technology0 sites30 target enrollmentFebruary 23, 2023

Overview

No summary available.

Registry

who.int

Start Date

February 23, 2023

End Date

TBD

Last Updated

3 years ago

Study Type

Observational

Sex

All

Sponsor

•1\.Healthy Controls
•Male and female participants aged 21\-60 years.
•Willing and able to provide written informed consent.
•Understands and is willing and able to comply with all study procedures.
•Fluent in written and spoken English.
•Normal vision or corrected with contact lenses.
•Currently hold a (full) drivers’ licence (no ‘P\-platers’) and are active drivers (at least once/week), with at least three years of driving experience.
•No history of use of illicit amphetamine substances \[amphetamine, methamphetamine, methylenedioxymethamphetamine (MDMA)]
•No use of other illicit substances or recreational (off\-target) use of prescription medication either in past 12 months
•Absence of lifetime chronic/binge drug use (self\-report)

•1\.Healthy Controls
•Unable to understand or comply with testing procedures.
•Inability to speak or read English.
•Taking any form of medication within one week of admission (except for prophylactic antibiotics, contraceptive pill, or other routine medications to treat benign conditions, such as antibiotics to treat acne) and agree not to take any medication throughout the study
•Unable to participate in scheduled visit, treatment plan, tests, and other study procedures according to the protocol.
•Currently under administrative or legal supervision.
•2\.People who use methamphetamine
•Unable to understand or comply with testing procedures.
•Inability to speak or read English.
•Unable to participate in scheduled visit, treatment plan, tests and other study procedures according to the protocol (e.g., unable to abstain from methamphetamine for 12 hours prior to study session).